Technegas® for Asthma
Asthma
Phase 2Active
Key Facts
About Cyclomedica
Global leader in nuclear pulmonary imaging with Technegas® for diagnosis and management of respiratory diseases.
View full company profileTherapeutic Areas
Other Asthma Drugs
| Drug | Company | Phase |
|---|---|---|
| Asthma Candidate | Teva | Phase 3 |
| Montelukast Amorphous Form | Morepen Laboratories | Phase-2 |
| Chitinase Inhibitor | Lead Discovery Siena | Discovery |
| RIG-101 | RIGImmune | Pre-clinical |
| SKB378 | Klus Pharma | Phase 1 |
| Asthma Clinical Trials | American Health Research | Not Disclosed |
| Advanced Asthma Products | Polpharma | Not Disclosed |
| Solrikitug | Uniquity Bio | Phase 2 |
| Asthma Trial | Science 37 | Phase 3 |
| CAL-4 | Calyxha Biotechnologies | Preclinical |
| Digital Biomarker for Asthma | electronRx | Early Development |
| Flutiform | KYORIN Pharmaceutical | Marketed |